Achillion to Present at Two Upcoming Investor Conferences

NEW HAVEN, Conn., March 1, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that members of the senior management team will be presenting a company overview at two upcoming investor conferences:

  • Cowen and Company 33rd Annual Health Care Conference on Monday, March 4, 2013 at 2:50 p.m. ET at The Boston Marriott Copley Place in Boston, MA; and
  • Barclay Global Healthcare Conference on Wednesday, March 13, 2013 at 8:00 a.m. ET at the Loews Miami Hotel in Miami, FL.

The live audio broadcasts and the subsequent archived webcasts of the Company's presentations will be available on the Company's website,, under the "News Center" section. The audio recording will be archived for 30 days following the live presentation. Please connect to Achillion's website several minutes prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary.

About Achillion Pharmaceuticals

Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. Achillion's proven discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused on solutions for the most challenging problems in infectious disease including hepatitis C and resistant bacterial infections. For more information on Achillion Pharmaceuticals, please visit or call 1-203-624-7000.

CONTACT: Company Contact: Glenn Schulman Achillion Pharmaceuticals, Inc. Tel. (203) 624-7000 Investors: Mary Kay Fenton Achillion Pharmaceuticals, Inc. Tel. (203) 624-7000 Media: Christin Culotta Miller Ogilvy PR Tel. (212) 880-5264 Investors: Seth Lewis The Trout Group, LLC Tel. (646) 378-2952 slewis@troutgroup.comSource:Achillion Pharmaceuticals, Inc.